Evidence map›Paper›PMID 36809150›Full record

Trial reportJournal of child and adolescent psychopharmacology2023

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.

Ann C Childress, Andrea Marraffino, Andrew J Cutler, Charles Oh, Matthew N Brams

Open access · hybridFull text readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Advances in management of sarcoidosis-associated fatigue: A narrative review.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Ann C ChildressCenter for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, USA.ORCID 0000-0001-5782-7891
Andrea MarraffinoAccel Research Sites Network, Maitland, Florida, USA.
Andrew J CutlerSUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0001-5800-0378
Charles OhCorium, LLC, Boston, Massachusetts, USA.
Matthew N BramsBayou City Research, Houston, Texas, USA.
Baylor College of Medicine · USCenter for Psychiatry and Behavioral Medicine · USCorium (United States) · USNeurosciences Institute · USResearch Network (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsDexmethylphenidate HydrochlorideMethylphenidateChildDelayed-Action PreparationsDose-Response Relationship, DrugDouble-Blind MethodHumansTreatment OutcomeCentral Nervous System StimulantsDelayed-Action PreparationsDexmethylphenidate HydrochlorideMethylphenidateserdexmethylphenidate and dexmethylphenidateADHD-RS-5CGI-SdexmethylphenidatesafetySDX/d-MPHserdexmethylphenidate

Identifiers

PMID36809150
PMCPMC10031142
OpenAlexW4321446463

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read113
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.